ClinConnect ClinConnect Logo
Search / Trial NCT04323007

Thyroid Dysfunction in Patients With Nephrotic Syndrome

Launched by MERNA MAKRAM · Mar 25, 2020

Trial Information

Current as of June 20, 2025

Unknown status

Keywords

ClinConnect Summary

Nephrotic syndrome (NS) is one of the most popular glomerular diseases all over the world It result in loss of various macromolecules which exist in the plasma and bound to plasma proteins. They are carried away and lost in the urine due to increase glomerular membrane permeability.The abnormalities arising as a result of persistence of generalized edema , substantial heavy proteinuria \>3,5 gm/24 h 3, hypoalbuminemia\<30 g/L and hyperlipidemia Also, nephrotic syndrome may associated with thromboembolism and increase risk of infection, vitamin D deficiency, Iron deficiency and endocrine abn...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Nephrotic syndrome defined by the following:
  • 1. Generalized edema
  • 2. Urine protein excretion \> 3,5 g/24 hours
  • 3. Urine protein to creatinine ratio \> 3,500mg/g
  • 4. Serum albumin level less than 30 g/L
  • Exclusion Criteria:
  • - 1) Patients \< 18 years old 2) Patients who have Thyroid diseases, current or past history of thyroid hormone or antithyroid drug intake.
  • 3) Patients who have diabetes mellitus or autoimmune diseases as systemic lupus erythematosus and RA 4) Medications known to affect thyroid function. 5) Patients with liver cirrhosis and chronic liver disease as augmentin

About Merna Makram

Merna Makram is a dedicated clinical trial sponsor focused on advancing medical research and innovation. With a commitment to improving patient outcomes, the organization specializes in the development and management of clinical trials across various therapeutic areas. Leveraging a robust network of clinical sites and a team of experienced professionals, Merna Makram strives to ensure the highest standards of compliance and ethical conduct in research. Their mission is to facilitate groundbreaking studies that contribute to the understanding and treatment of diseases, ultimately enhancing healthcare solutions for communities worldwide.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials